Paul v. Virginia (1868)

Paul v. Virginia was a landmark decision by the U.S. Supreme Court in 1868 that clarified the federal government's limited role in regulating insurance. This case established that insurance is not interstate commerce and, therefore, is not subject to federal regulation under the Commerce Clause of the U.S. Constitution.

Key features of Paul v. Virginia:

  • State Regulation: The decision upheld the traditional approach to insurance regulation, which delegated primary regulatory power to the individual states. This meant that states had the authority to regulate and oversee insurance companies operating within their borders.

  • Interstate Commerce: The Court ruled that insurance transactions are not part of interstate commerce, and therefore are not subject to federal regulation under the Commerce Clause of the U.S. Constitution. This decision established the foundation for the McCarran-Ferguson Act of 1945, which gave states the authority to regulate insurance.

  • Impact on Employee Benefits: The Paul v. Virginia decision has had a significant impact on the regulation of employee benefits, particularly in the areas of health and disability insurance. Because insurance is regulated at the state level, there is significant variation in the rules and regulations governing employee benefits across different states. This has made it challenging for employers to design and administer benefit plans that comply with all applicable state regulations.

Next Up

A Texas court ruled that American Airlines breached its ERISA duty of loyalty by failing to properly oversee BlackRock’s ESG-driven investment decisions. The decision could put millions of employers at legal risk if upheld. Are ESG investments in retirement plans now a liability?
The latest economic release from the Bureau of Labor Statistics reports that the U.S. job market added just under 150 thousand jobs last month while unemployment ticked down one-tenth of a point to 4% to close out the last such economic report with data collected under the Biden administration.
Centers of Excellence (COEs) may have peaked. While mid-sized employers increased adoption, the largest companies are scaling back. Is this a temporary dip or a shift in employer healthcare strategy?